Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Sci ; 13(21): 6262-6269, 2022 Jun 01.
Article in English | MEDLINE | ID: mdl-35733895

ABSTRACT

A new class of biaryl chiral ligands derived from 1,2-diaminocyclohexane (1,2-DACH) has been designed to enable the asymmetric addition of aliphatic and, for the first time, aromatic Grignard reagents to ketones for the preparation of highly enantioenriched tertiary alcohols (up to 95% ee). The newly developed ligands L12 and L12' together with the previously reported L0 and L0' define a set of complementary chiral promoters, which provides access to the modular construction of a broad range of structurally diverse non-racemic tertiary alcohols, bearing challenging quaternary stereocenters. The present advancements bring to completion our asymmetric Grignard methodology by expanding the scope to aromatic organomagnesium reagents, while facilitating its implementation in organic synthesis thanks to improved synthetic routes for the straightforward access to the chiral ligands. The synthetic utility of the method has been demonstrated by the development of a novel and highly enantioselective formal synthesis of the antihistamine API clemastine via intermediate (R)-3a. Exploiting the power of the 3-disconnection approach offered by the Grignard synthesis, (R)-3a is obtained in 94% ee with ligand (R,R)-L12. The work described herein marks the finalization of our ongoing effort towards the establishment of an effective and broadly applicable methodology for the asymmetric Grignard synthesis of chiral tertiary alcohols.

2.
Health Phys ; 115(5): 590-599, 2018 11.
Article in English | MEDLINE | ID: mdl-30260849

ABSTRACT

Due to heightened fear surrounding the possibility of future terrorism involving nuclear weapons and radiological dispersive devices, compounded by nonroutine nuclear power plant releases such as from emergencies or accidents, interest in contamination levels of environmental radiation has spiked. This project sought to develop a continuously operational radiation-monitoring system, with graphically visualized data easily accessible to the public. Because this continuing project is housed at a university facility, it bears no connection to perceived political or commercial interests, generally increasing the credibility of the endeavor. Outdoor weather and radiation parameters were gathered by sensors installed on the rooftop of a two-story building. A display and cloud service website was used to project the live data in an understandable format. A correlation was observed between weather and visibly heightened levels of gamma radiation. The goal of this paper is to share and highlight the overall hardware selection and the unique software challenges encountered when developing a robust collection and analysis system, along with the challenges of displaying meteorological and radiological data in a clear and concise fashion.


Subject(s)
Radiation Exposure , Radiation Monitoring , Weather , Access to Information , Data Display , Internet , Radiation Monitoring/methods , Software , Spectrometry, Gamma
3.
Cancer Res ; 67(3): 1254-61, 2007 Feb 01.
Article in English | MEDLINE | ID: mdl-17283162

ABSTRACT

The transcription factor signal transducer and activator of transcription (STAT) 1 can mediate antiproliferative and proapoptotic effects in cancer cells, and a number of mechanisms have been found whereby STAT1 signaling is attenuated in tumors thereby increasing their malignant behavior. Thus, enhancing gene transcription mediated by STAT1 may be an effective approach to cancer therapy. A high-throughput screen was developed to identify molecules that could enhance STAT1-dependent gene expression. Through this approach, it was found that 2-(1,8-naphthyridin-2-yl)phenol (2-NP) caused a 2-fold increase in STAT1-dependent reporter gene expression compared with that seen with maximally effective concentrations of IFN-gamma alone. This effect was specific to STAT1 because 2-NP had no effect on unrelated transcription factors such as nuclear factor (NF) kappaB or the highly homologous transcription factor STAT3. STAT1-dependent gene activation was enhanced by this compound in a variety of human and murine cell lines and was independent of the stimulus used. Furthermore, 2-NP enhanced the expression of the bona fide endogenous STAT1 target gene interferon regulatory factor 1. 2-NP increased the duration of STAT1 tyrosine phosphorylation in response to IFN-gamma, and this may underlie its enhancement of STAT1-dependent transcription. Reflecting the fact that STAT1 can exert tumor-suppressive effects, 2-NP enhanced the ability of IFN-gamma to inhibit the proliferation of human breast cancer and fibrosarcoma cells. Tumor cells lacking STAT1 were unaffected by either IFN-gamma or 2-NP. These findings indicate that enhancement of STAT1 transcriptional activity may have utility in anticancer therapies, and that cell-based screens for modulators of transcription factor function can be a useful approach for drug discovery.


Subject(s)
Interferon-gamma/pharmacology , STAT1 Transcription Factor/biosynthesis , Transcription, Genetic/drug effects , Animals , Cell Growth Processes/drug effects , Cell Line, Tumor , Drug Synergism , Gene Expression Regulation/drug effects , Humans , Mice , NIH 3T3 Cells , Naphthyridines , Phosphorylation/drug effects , STAT1 Transcription Factor/genetics , STAT1 Transcription Factor/metabolism , Transcriptional Activation
4.
Cancer Res ; 66(7): 3649-57, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16585190

ABSTRACT

To determine the role of the transcription factor signal transducer and activator of transcription (STAT) 1 on endothelial cell function, human umbilical vein endothelial cells (HUVEC) were treated with IFN-gamma, a potent activator of STAT1. IFN-gamma inhibited cell growth and tube formation of HUVECs. Although the potent proangiogenic protein vascular endothelial growth factor (VEGF) stimulated cell growth and tube formation, IFN-gamma could suppress these effects of VEGF. Transfection of HUVECs with short interfering RNA targeting STAT1 abrogated IFN-gamma-induced inhibition of HUVEC growth and tube formation, and suppressed the inhibition of VEGF-induced tube formation by IFN-gamma, indicating that STAT1 is critical for this process. IFN-gamma blocks the biological activity of VEGF through inhibition of genes necessary for the VEGF response, including angiopoietin-2, urokinase plasminogen activator, tissue inhibitor of matrix metalloproteinase-1, cyclooxygenase-2, and VEGF receptor 2. To extend these findings in vivo, the role of STAT1 in angiogenesis was examined in STAT1-deficient mice using the Matrigel in vivo angiogenesis assay. Substantial cellular infiltration and formation of vascular structures occurred in STAT1-/- mice compared with wild-type controls. These data indicate that STAT1 plays a key role in the inhibition of angiogenesis through its action within endothelial cells, and exploiting this process may be useful in treating cancers and vascular tumors.


Subject(s)
Endothelial Cells/cytology , Neovascularization, Physiologic/physiology , STAT1 Transcription Factor/metabolism , Cell Growth Processes/drug effects , Cell Growth Processes/physiology , Endothelial Cells/drug effects , Humans , Interferon-gamma/pharmacology , Neovascularization, Physiologic/drug effects , Phosphorylation/drug effects , RNA, Small Interfering/genetics , Recombinant Proteins , STAT1 Transcription Factor/antagonists & inhibitors , STAT1 Transcription Factor/genetics , Transfection , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/pharmacology , Vascular Endothelial Growth Factor Receptor-2/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...